EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing

Alejandra Mosteiro, Diouldé Diao iD, Carmen Bedia iD, Leire Pedrosa iD, Gabriela Ailén Caballero iD, Iban Aldecoa iD, Mar Mallo iD, Francesc Solé iD, Ana Sevilla iD, Abel Ferrés iD, Gloria Cabrera, Marta Muñoz-Tudurí iD und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26188889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alejandra Mosteiro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Oncological Neurosurgery, Neurosurgery Service, Hospital Clinic de Barcelona-FCRB, 08036 Barcelona, Spain. Hauptthemen laut MEDLINE: Glioblastoma, Photochemotherapy, Organoids, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gebro Pharma (Spain), Asociación Española Contra el Cáncer, Josep Carreras Leukaemia Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GB) is one of the most aggressive brain tumors, characterized by high infiltrative capacity that enables tumor cells to invade healthy brain tissue and evade complete surgical resection. This invasiveness contributes to resistance against conventional therapies and a high recurrence rate. Strategies capable of eliminating residual tumor cells are urgently needed. Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA), an FDA- and EMA-approved compound, induces selective accumulation of the photosensitizer protoporphyrin IX (PpIX) in metabolically active tumor cells, enabling targeted cytotoxicity through light activation. A major limitation to its clinical application is the unclear variation in the cytotoxic effect of PDT according to individual tumoral differences. In this study, we propose and validate an in vivo model of patient-derived GB initiating cells (GICs) and brain organoids to test the effects of PDT. First, patient-derived GICs were molecularly characterized by flow cytometry and copy number variation profiling using OncoScan CNV Assays, then co-cultured with human brain organoids to generate a hybrid model recapitulating key aspects of the tumor microenvironment. 5-ALA photodynamic therapy (PDT) efficacy was assessed in vitro by GFP-based viability measurements, LDH release assays, and TUNEL staining. Then, a murine model was generated to study PDT in vivo, based on a heterotopic (renal subcapsular engraftment) xenograft of the GICs-human brain organoid co-culture. PDT was tested in the model; in each subject, one kidney tumoral engraftment was treated and the contralateral served as a control. Immunofluorescence analysis was used to study the cell composition of the brain organoid-tumoral engraftment after PDT, and the effects on non-GIC cells. The antitumoral effect was determined by the degree of cell death analysis with the TUNEL technique. The GICs-brain organoid co-culture resulted in tumoral growth and infiltration both in vitro and in vivo. The pattern of growth and infiltration varied according to the tumoral genetic profile. 5-ALA PDT resulted in a reduction in the number of GICs and an increase in apoptotic cells in all four lines tested in vitro. A correlation was found between the induced phototoxicity in vivo with the molecular typification of GICs cell lines in vitro. There were no changes in the number or distribution of neuronal cells after the application of PDT, while a reduction in active astrocytes was observed. 5-ALA PDT could be effective in eradicating GICs with a heterogeneous molecular profile. The hybrid human-murine model presented here could be useful in investigating adjuvant therapies in GB, under the concept of personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPhotochemotherapyOrganoidsBrain NeoplasmsNeoplastic Stem CellsAnimalsHumansMiceAminolevulinic AcidPhotosensitizing AgentsDisease Models, AnimalXenograft Model Antitumor AssaysProtoporphyrinsCell Line, TumorBrain

Stichwörter der Autor:innen

5-ALAglioblastomamodelorganoidphotodynamic therapy

Substanzen

Aminolevulinic AcidPhotosensitizing Agentsprotoporphyrin IXProtoporphyrins

Autor:innen und Institutionen

  • Laboratory of Experimental Oncological Neurosurgery, Neurosurgery Service, Hospital Clinic de Barcelona-FCRB, 08036 Barcelona, Spain.
  • Department of Neurosurgery, Hospital Clínic de Barcelona, Universitat de Barcelona, 08036 Barcelona, Spain.
  • Institute of Environmental Assessment and Water Research (IDAEA-CSIC), 08034 Barcelona, Spain.
  • Department of Pathology, Biomedical Diagnostic Center, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
  • Neurological Tissue Bank of the Biobank, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Microarrays Unit, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.

ORCID-Profile: Diouldé Diao, Carmen Bedia, Leire Pedrosa, Gabriela Ailén Caballero, Iban Aldecoa, Mar Mallo, Francesc Solé, Ana Sevilla, Abel Ferrés, Marta Muñoz-Tudurí, Estela Pineda, José Juan González Sánchez

Förderung

  • Gebro Pharma (Spain)
  • Asociación Española Contra el Cáncer
  • Josep Carreras Leukaemia Research Institute
  • European Union
  • Generalitat de Catalunya
  • Laboratorios Gebro Pharma S.A.
  • Spanish Association Against Cancer
  • 2021 SGR 00560 (GRC) Generalitat de Catalunya

Zitieren

APA

Mosteiro, A., Diao, D., Bedia, C., Pedrosa, L., Caballero, G. A., Aldecoa, I., Mallo, M., Solé, F., Sevilla, A., Ferrés, A., Cabrera, G., Muñoz-Tudurí, M., Centellas, M., Pineda, E., Jiménez, À. S., & González Sánchez, J. J. (2025). A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188889

Vancouver

Mosteiro A, Diao D, Bedia C, Pedrosa L, Caballero GA, Aldecoa I, et al. A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188889

BibTeX
@article{Mosteiro2025,
  author = {Mosteiro, Alejandra and Diao, Diouldé and Bedia, Carmen and Pedrosa, Leire and Caballero, Gabriela Ailén and Aldecoa, Iban and Mallo, Mar and Solé, Francesc and Sevilla, Ana and Ferrés, Abel and Cabrera, Gloria and Muñoz-Tudurí, Marta and Centellas, Marc and Pineda, Estela and Jiménez, Àngels Sierra and González Sánchez, José Juan},
  title = {A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26188889}
}
Kostenlos starten →